Supporting mental health workforce development through self-directed learning, supported learning and blended approaches: an empirical study in youth mental health.
Making a real difference in Youth Mental Health!!!
A University of Melbourne and Orygen collaboration that brings together academic and mental health expertise (Prof Stephen Wood, A/Prof Gillinder Bedi and Tahnee Bridson) to drive innovation and deliver real-world impact.
Project Overview:
The project, titled ” GAMMA C,” focuses on identifying which consumers will benefit from early imitation of clozapine, a medication used to treat schizophrenia. Clozapine is a very effective medication but it can have serious side effects in rare cases. This means that it is often only tried very late in the illness course when it may be too late. This project aims to allow us to develop a predictive model to determine who should be given clozapine.
Value for Industry:
Orygen “believe that all young people deserve to grow into adulthood with optimal mental health. Working with young people, our partners and one another, we’re redefining what’s possible in youth mental health research, policy, innovative clinical services and evidence-based training and education to ensure continuous improvement in the treatments and care provided to young people. The results from this innovative GAMMA C project will produce impactful research that will inform not only further research and clinical decisions in the prevention and treatment of mental ill-health, but also develop new models of care for young people with emerging disorders and their families”.
Value for Academia
Professor Stephen Wood comments that “This collaboration between Orygen, the University of Melbourne and the Commonwealth is very welcomed. We train the very best clinicians, we work on internationally competitive research issues, and we graduate the very best students in all areas of health, medicine and biomedical research. We are proud to be part of a thriving, innovative ecosystem of health and biomedical organisations across Victoria. These partnerships support and amplify our impact on the health and wellbeing of our communities”.
PhD Candidate’s Perspective:
Tahnee Bridson comments that “as a research student and a psychiatrist in training, this is really important for clinicians so that we can tailor treatment to suit individual patients. The outcomes from this project with Orygen will help ensure everyone is commenced on the right medication for them at the beginning of their illness”. For more info please visit: https://www.orygen.org.au/
For more info regarding the National Industry PhD Program visit: https://lnkd.in/gpVsGZZ6
Thanks to Matt Atkins, Mitch S. and Sinn Yuin Chong for all your help.